These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 30232517)

  • 21. Comparison between Glioblastoma and Primary Central Nervous System Lymphoma Using MR Image-based Texture Analysis.
    Kunimatsu A; Kunimatsu N; Kamiya K; Watadani T; Mori H; Abe O
    Magn Reson Med Sci; 2018 Jan; 17(1):50-57. PubMed ID: 28638001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences between primary central nervous system lymphoma and glioblastoma: topographic analysis using voxel-based morphometry.
    Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Momosaka D; Hata N; Akagi Y; Suzuki SO; Iwaki T; Iihara K; Honda H
    Clin Radiol; 2019 Oct; 74(10):816.e1-816.e8. PubMed ID: 31400805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
    Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
    J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
    Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
    J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
    Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
    Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Kong Z; Jiang C; Zhu R; Feng S; Wang Y; Li J; Chen W; Liu P; Zhao D; Ma W; Wang Y; Cheng X
    Neuroimage Clin; 2019; 23():101912. PubMed ID: 31491820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomics Analysis of Diffusion Kurtosis Imaging: Distinguishing Between Glioblastoma and Single Brain Metastasis.
    Gao E; Wang P; Bai J; Ma X; Gao Y; Qi J; Zhao K; Zhang H; Yan X; Yang G; Zhao G; Cheng J
    Acad Radiol; 2024 Mar; 31(3):1036-1043. PubMed ID: 37690885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of high-grade glioma and primary central nervous system lymphoma: Multiparametric imaging of the enhancing tumor and peritumoral regions based on hybrid
    Zhang S; Wang J; Wang K; Li X; Zhao X; Chen Q; Zhang W; Ai L
    Eur J Radiol; 2022 May; 150():110235. PubMed ID: 35290912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques.
    Bathla G; Priya S; Liu Y; Ward C; Le NH; Soni N; Maheshwarappa RP; Monga V; Zhang H; Sonka M
    Eur Radiol; 2021 Nov; 31(11):8703-8713. PubMed ID: 33890149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T
    Sun YZ; Yan LF; Han Y; Nan HY; Xiao G; Tian Q; Pu WH; Li ZY; Wei XC; Wang W; Cui GB
    BMC Med Imaging; 2021 Feb; 21(1):17. PubMed ID: 33535988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.
    Lee B; Park JE; Bjørnerud A; Kim JH; Lee JY; Kim HS
    AJNR Am J Neuroradiol; 2018 Aug; 39(8):1415-1422. PubMed ID: 30026384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classification of glioblastoma versus primary central nervous system lymphoma using convolutional neural networks.
    McAvoy M; Prieto PC; Kaczmarzyk JR; Fernández IS; McNulty J; Smith T; Yu KH; Gormley WB; Arnaout O
    Sci Rep; 2021 Jul; 11(1):15219. PubMed ID: 34312463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioblastoma and primary central nervous system lymphoma: Preoperative differentiation by using MRI-based 3D texture analysis.
    Xiao DD; Yan PF; Wang YX; Osman MS; Zhao HY
    Clin Neurol Neurosurg; 2018 Oct; 173():84-90. PubMed ID: 30092408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling.
    Yu X; Hong W; Ye M; Lai M; Shi C; Li L; Ye K; Xu J; Ai R; Shan C; Cai L; Luo L
    Eur Radiol; 2023 Aug; 33(8):5357-5367. PubMed ID: 37171492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An integrative non-invasive malignant brain tumors classification and Ki-67 labeling index prediction pipeline with radiomics approach.
    Zhang L; Liu X; Xu X; Liu W; Jia Y; Chen W; Fu X; Li Q; Sun X; Zhang Y; Shu S; Zhang X; Xiang R; Chen H; Sun P; Geng D; Yu Z; Liu J; Wang J
    Eur J Radiol; 2023 Jan; 158():110639. PubMed ID: 36463703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models.
    Kickingereder P; Burth S; Wick A; Götz M; Eidel O; Schlemmer HP; Maier-Hein KH; Wick W; Bendszus M; Radbruch A; Bonekamp D
    Radiology; 2016 Sep; 280(3):880-9. PubMed ID: 27326665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential Diagnostic Value of Texture Feature Analysis of Magnetic Resonance T2 Weighted Imaging between Glioblastoma and Primary Central Neural System Lymphoma.
    Wang BT; Liu MX; Chen ZY
    Chin Med Sci J; 2019 Mar; 34(1):10-17. PubMed ID: 30961775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging.
    Radbruch A; Wiestler B; Kramp L; Lutz K; Bäumer P; Weiler M; Roethke M; Sahm F; Schlemmer HP; Wick W; Heiland S; Bendszus M
    Eur J Radiol; 2013 Mar; 82(3):552-6. PubMed ID: 23238364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a machine learning algorithm for predicting diffuse midline glioma, H3 K27-altered, H3 K27 wild-type high-grade glioma, and primary CNS lymphoma of the brain midline in adults.
    Lv K; Chen H; Cao X; Du P; Chen J; Liu X; Zhu L; Geng D; Zhang J
    J Neurosurg; 2023 Aug; 139(2):393-401. PubMed ID: 36681946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation between glioblastoma, brain metastasis and subtypes using radiomics analysis.
    Artzi M; Bressler I; Ben Bashat D
    J Magn Reson Imaging; 2019 Aug; 50(2):519-528. PubMed ID: 30635952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.